The SEC Postpones Reg SHO Amendments

The SEC has  issued an exemptive order extending  the deadline for the 2023 amendments to the Exchange Act Rule 13f-2 and Form SHO to January 2, 2028,  a two-year addition to their  initial  January 2, 2026,  extension  issued  in February 2025.  The first filing under  the new requirements, which was  first due  on February 14, 2025, then extended to February 14, 2026, is now moved to February 14, 2028.

The 2023 amendments required: 

  • Institutional investment managers holding short positions exceeding $10 million or 2.5% of a company’s shares  to report their total short positions in that  stock at the end of the month.
  • Institutional investment managers are to report  their net activity (including options) in the stock on each settlement date during the month.

The increased transparency,  mandated by the Dodd Frank Wall Street Reform and Consumer Protection Act of 2019,  was intended to enhance the SEC’s  ability  to detect market manipulation and protect against systemic risks that could destabilize the market.  Several industry associations sued the SEC to overturn the amendments  contending that  the SEC  should have considered  the  economic effect of the rule 13f-2 amendments  together with the economic impact of  new rule 10c-1a, which requires reporting of certain securities loans.

On August 25, 2025, a three-judge panel of the Fifth Circuit Court of Appeals  agreed with this argument and  remanded the case to the SEC to evaluate the cumulative  economic impact of these rules.

The text of the December 3 order and the length of the extension both suggest that the SEC intends to use this opportunity to modify the 2023 amendments  substantially before they take effect.  Commissioner Caroline Crenshaw issued a  statement challenging the lawfulness of this action, characterizing the Commission’s action as “repeal by extension.”

ACA will continue to  monitor  the SEC’s progress and provide updates accordingly.

Guiding Firms Through SEC Reporting Requirements with Proven Compliance Expertise

ACA’s regulatory specialists partner with firms to identify risks, close compliance gaps, and implement strong, sustainable controls that withstand regulatory scrutiny. Our team brings deep technical expertise and real-world insight to help you stay aligned with the SEC’s expectations, as they continue to evolve.

Our solutions include:

  • Outsourcing with confidence: Rely on ACA to manage the drafting, review, and submission of your U.S., UK, and EU regulatory filings with precision and consistency.
  • Operational efficiency: Free your team to focus on higher-value initiatives while we take on the routine, but business-critical work of preparing and submitting regulatory filings.
  • Risk mitigation and resiliency: Strengthen your firm’s compliance posture with ACA’s proactive oversight, reducing filing errors, operational risks, and downstream regulatory exposure.

Contact an expert to ensure your compliance program is prepared for unexpected regulatory changes.